LCTX
Lineage Cell Therapeutics Inc
Price:  
0.61 
USD
Volume:  
1,483,361.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LCTX WACC - Weighted Average Cost of Capital

The WACC of Lineage Cell Therapeutics Inc (LCTX) is 8.9%.

The Cost of Equity of Lineage Cell Therapeutics Inc (LCTX) is 8.90%.
The Cost of Debt of Lineage Cell Therapeutics Inc (LCTX) is 8.70%.

Range Selected
Cost of equity 7.50% - 10.30% 8.90%
Tax rate 4.20% - 6.50% 5.35%
Cost of debt 7.00% - 10.40% 8.70%
WACC 7.5% - 10.3% 8.9%
WACC

LCTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.79 0.97
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.50% 10.30%
Tax rate 4.20% 6.50%
Debt/Equity ratio 0 0
Cost of debt 7.00% 10.40%
After-tax WACC 7.5% 10.3%
Selected WACC 8.9%